Praneet K. Sharma, MD


Medical School – Seth GS Medical College, Mumbai

Internship – Clevland Clinic Foundation, Cleveland, OH

Residency – Clevland Clinic Foundation, Cleveland, OH

Fellowship – Cleveland Clinic Foundation GME Office, Cleveland, OH | University of Missiouri-Kansas City, MO

Specializing In

Cardiologist in Mesa and Gilbert, AZ

Dr. Praneet K. Sharma is Board Certified in Cardiovascular Disease, Interventional Cardiology, Echocardiography and Internal Medicine. He has received his Cardiology training at Cleveland Clinic.

Dr. Sharma specializes in performing coronary interventions (heart artery blockages), peripheral vascular interventions (blockages in artery to limbs), peripheral arterial interventions (opening blockages in arteries of the limb), and structural interventions (such as heart valve damage) with a catheter based technique. He has a special interest in catheter-based treatment of heart artery blockages from the wrist (Radial catheterization). He also provides venous care, performing interventions for patients with venous insufficiency (such as varicose veins and leg ulcers).

Dr. Sharma believes in promotion of health among people at risk for heart disease (primary prevention-before heart and vascular disease has happened), as well as among those who have developed heart disease (secondary prevention).

Video Library

Dr. Praneet Sharma discusses his decision to become a physician and the vein treatment capabilities of the Tri-City Vein Center.



  • First Prize at the Annual Research Day- Internal Medicine Residency at Cleveland Clinic June 2009.


  • Research Fellow 2013-2014. Research training during the first year of interventional cardiology fellowship.
  • New England Journal of Medicine course for residents and fellows May 2014: Understanding the Peer Review Literature.
  • Clinical Scholar September 2008-January 2009. Completed advance research track within Internal Medicine Residency program.

Poster Presentations:

  • 2014: Association of Body Mass Index with Health Status Outcomes in Patients Undergoing Percutaneous Coronary Intervention. Poster presentation at the AHA: Quality of Care and Outcomes Research 2014 Scientific Sessions on June 4, 2014 in Baltimore, MD. Published in Circ Cardiovasc Qual Outcomes. 2014;7:A332.
  • 2014: Obesity Paradox and Angina Frequency in Patients Presenting With Acute Myocardial Infarction. Poster presentation at ACC Scientific Sessions on March 29-31st, Washington D.C. Published in J Am Coll Cardiol. 2014;63(12_S).
  • 2014: Weight Change and Angina Frequency in Patients Presenting With Acute Myocardial Infarction. Poster presentation at ACC Scientific Sessions on March 29-31st, Washington D.C.Published in J Am Coll Cardiol. 2014;63(12_S).
  • 2009: Impact of Sildenafil on Cardiac Structure and Function in Patients with Pulmonary Arterial Hypertension. Poster presented at: HFSA-scientific sessions 2009; Boston, MA.

Oral Presentations:

  • 2014: Cardiovascular Grand Rounds at Saint Luke’s Mid America Heart Institute/University of Missouri-Kansas CityControversies in Acute Myocardial Infarction Care.
  • 2014:  Oral presentation at AHA Scientific session in Chicago. Clinical Characteristics and Temporal Trends among Patients Presenting Late (>12 hours after symptom onset) with ST-Elevation Myocardial Infarction – A Report from the NCDR®.
  • 2014: Oral presentation at AHA Scientific session in Chicago. Angina Frequency and Unplanned Readmissions after Multivessel vs. Culprit Vessel only Percutaneous Coronary Intervention Strategy Among Patients Presenting with Acute Myocardial Infarction- 6 week Outcomes from the TRANSLATE-ACS Observational Study.
  • 2012: AHA Scientific Sessions 2012, Los Angeles, CA. Hemoglobin A1c Predicts Long-term Mortality Amongst Diabetic Patients Undergoing Percutaneous Coronary Intervention.
  • 2009: Pulmonary Hypertension Summit 2009 Translating Discoveries Into Patient Care; Cleveland Clinic, Cleveland, OH. Impact of Sildenafil on Cardiac Structure and Function in PAH.

Peer Reviewed Journal Articles/Abstracts:

  • Sharma Praneet K. Agarwal S, Ellis S.G, Goel S, Cho L, Tuzcu E.M., Lincoff A.M., Kapadia S.R. Association of Glycemic Control with Mortality in Patients with Diabetes Undergoing Percutaneous Coronary Intervention. Accepted for publication Circulation: Cardiovascular Interventions May 2014.
  • Kureshi F, Kennedy KF, Jones PG, Thomas RJ, Buchanan DM, Sharma P, Fendler T, Arnold SV, Ho PM, Nallamothu BK, Spertus JA. Association Between Cardiac Rehabilitation Participation and Health Status Outcomes After Acute Myocardial Infarction. Circ Cardiovasc Qual Outcomes. 2014;7:A27
  • Kumar P, Francis G S, Tang WHW. Phosphodiesterase 5 inhibition in heart failure: mechanisms and clinical implications. Nature Reviews Cardiology. 2010 May; 6(5): 349-355.
  • Tang WHW, Thakur A, Kumar P, Kanderian A, Borowski AG, Francis GS. Increased Exhaled Nitric Oxide Levels in Ambulatory Patients with Chronic Systolic Heart Failure Following Exercise: Importance of Pulmonary Venous Hypertension. J. Am. Coll. Cardiol. 2010 Mar; 55(10A): A34.E325.
  • Tang WHW, Wang Z; Thakur A; Kumar P; Borowski AG; Shrestha K; Hazen SL. Determinants of Impaired Nitric Oxide Synthesis in Acute Decompensated Heart Failure. Circulation. 2009 Nov; 120(18): S878.

Book Chapters:

  • Kumar P, Faulx M. Chapter: Cardiac Catheterization- Right and Left Heart Catheterization. Book: Cardiovascular Hemodynamics: An Introductory Guide. Editors: Anwaruddin, Martin, Stephens, Askari. Humana Press, First Edition. ISBN-10: 1607611945 | ISBN-13: 978-1607611943.
  • Kumar P, Tang WHW. Chapter: Pulmonary Hypertension. Book: Manual of Cardiovascular Medicine. Editor: Griffin. Wolters Kluwer/Lippincott Williams & Wilkins; Fourth Edition. ISBN-10: 1451131607 | ISBN-13: 978-145113160.